Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Strategic Partner
BIOPHARMACEUTICALS
Cardiovascular Devices
Prosthetic Heart Valve
Peripheral Vascular Devices
Cardiovascular Monitoring & Diagnostic Devices
Cardiovascular Surgery
Cardiac Rhythm Management
Cardiovascular Prosthetic Devices
Interventional Cardiology
Cardiac Assist Devices
Wound Care Management
Hospital Supplies
Syringes and Needles
Disposable Hospital & Surgical Supplies
Drug Delivery Devices
Inhalation Systems
Needle Free Injections
Infusion Systems
Diabetes Care Devices
Insulin Delivery & Glucose Monitoring
Ophthalmic Devices
Cataract Surgery Devices
Ophthalmic Diagnostic Equipment
Refractive Surgery Devices
ENT Devices
Hearing Implants
Diagnostic Devices
Electrosurgical Devices
Dental Equipment & Accessories
Diagnostic Imaging & MRI Systems
C/T Systems & Mammography Equipment
X-Ray & Ultrasound Systems
Nuclear Imaging Equipment
Contrast Media Injectors
Bone Densitometry
Anesthesia and Respiratory Devices
Anesthesia Machines & Disposables
Respiratory Devices & Disposables
Sleep Apnea Diagnostic Systems
Healthcare IT
Medical Imaging Information Systems
Nephrology and Urology Devices
Renal Dialysis Equipment
Orthopedic Devices
Orthobiologics & Arthroscopy
Joint Reconstruction
Trauma Fixation
Orthopedic Prosthetics
Cranium Maxillofacial Fixation (CMF)
Spinal Surgery
Endoscopy Devices & instruments
Rigid & Flexible Endoscope
In Vitro Diagnostics
Genetic Testing
Clinical Chemistry
Hematology
Immuno Chemistry
Infectious Immunology
Histology And Cytology
Patient Monitoring
Multiparameter Patient Monitoring
Micro-Electromechanical Systems
Non-invasive Blood Pressure Monitors
Neurology Devices
Neurostimulation Devices
Interventional Neurology
CSF Management
Neurosurgical Products
Radiosurgery
Diabetic Nephropathy
Diabetic Retinopathy
Hypercholesterolemia
Oral Mucositis
Gout
Acute Lymphocytic Leukemia
Bone Metastasis
Brain Cancer
Breast Cancer
Cervical Cancer
Chronic Lymphocytic Leukemia
Endometrial Cancer
Ewing Sarcoma
Gastric Cancer
Gastrointestinal Stromal Tumors
Head And Neck Cancer
Hodgkin Lymphoma
Kidney Cancer
Liver Cancer
Malignant Mesothelioma
Medullary Thyroid Cancer
Melanoma
Multiple Myeloma
Non-Hodgkin Lymphoma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Testicular Cancer
Thyroid Cancer
Age Related Macular Degeneration
Keratoconjunctivitis sicca (Dry Eye)
Retinal Vein Occlusion
Acute Respiratory Distress
Syndrome
Sepsis
Staphylococcal Infections
Acute Coronary Syndrome
Angina Pectoris
Atrial Fibrillation
Coronary Artery Disease (CAD)
Critical Limb Ischemia
Hypertension
Pulmonary Arterial Hypertension
Acute Pain
Anxiety Disorders
Chronic Pain
Dementia
Diabetic Neuropathy
Obsessive-Compulsive Disorder
Osteoarthritis Pain
Parkinson's Disease
Post-Traumatic Stress Disorder
Restless Legs Syndrome
Schizophrenia
Traumatic Brain Injury
Liver Cirrhosis
Childhood Enuresis
Growth Hormone Disorders
Hyperparathyroidism
Hyperthyroidism
Guillain-Barre Syndrome
Cytomegalovirus
Fungal Infections
Gram-Negative Bacterial Infections
H1N1 Infection
Herpes Zoster
HIV-1 Infection
Human Papillomavirus Infections
Staphylococcus Aureus (MRSA)
Chicago, Illinois
David
David B.
B. Loucks
Loucks
Chairman
Chairman &
& CEO
CEO
Fritz
Fritz Reichenbach
Reichenbach
Managing
Managing Member
Member
Christoph
Christoph Brandenberger
Brandenberger
Managing
Managing Director
Director
Victor
Victor Culiuc
Culiuc
Managing
Managing Director
Director
Andrew
Andrew Romer
Romer
Analyst
Analyst
Kimberly
Kimberly Szokol
Szokol
Analyst
Analyst
David
David Donnelly
Donnelly
Director
Institutional
Director Institutional Sales
Sales
Deborah
Deborah Herst
Herst
Vice
President
Marketing
Vice President Marketing
Scott
Scott Jordan
Jordan
Vice
Vice President
President
HealthiosXchange
HealthiosXchange
Greg
Greg Shearer
Shearer
Managing
Managing Director
Director
Boston, Massachusetts
Ellen
Ellen Baron
Baron
Managing
Managing Director
Director
Bangkok, Thailand
Jane
Jane Phornprapha
Phornprapha
Vice
Vice President
President
Vichaya
Vichaya Hanpiyavatanasakul
Hanpiyavatanasakul
Sr.
Sr.Analyst
Analyst
Gun
Gun Punyacharoensin
Punyacharoensin
Analyst
Analyst
Pollaratch
Pollaratch Wanichakul
Wanichakul
Analyst
Analyst
Kasama
Kasama Limpanukorn
Limpanukorn
Analyst
Analyst
Jessica
Jessica Liang
Liang
Research
Research Analyst
Analyst
Healthios Experience
Transaction Closes since Q3 2013
$52,000,000
Initial Public Offering`
NANOMIX, INC.
Has completed its $12,000,000
Equity financing by strategic and
financial investors
THE UNDERSIGNED ACTED AS EXCLUSIVE
ADVISOR TO NANOMIX
ALINE
AESTHETICS
MIACOM DIAGNOSTICS
Has completed its equity financing from
WELLFOUNT CORP.
Healthios Experience
Transaction Closes since Q3 2013 (cont)
CARDIOSOUTIONS, INC.
CRITICAL PERFUSION, INC.
Has entered into a co-development
agreement with
IRX Therapeutics
ORTHOCON, INC.
Confidential
Cardiovascular Devices
Prosthetic Heart Valve
Peripheral Vascular Devices
Cardiovascular Monitoring & Diagnostic Devices
Cardiovascular Surgery
Cardiac Rhythm Management
Cardiovascular Prosthetic Devices
Interventional Cardiology
Cardiac Assist Devices
Wound Care Management
Hospital Supplies
Syringes and Needles
Disposable Hospital & Surgical Supplies
Drug Delivery Devices
Inhalation Systems
Needle Free Injections
Infusion Systems
Diabetes Care Devices
Insulin Delivery & Glucose Monitoring
Ophthalmic Devices
Cataract Surgery Devices
Ophthalmic Diagnostic Equipment
Refractive Surgery Devices
ENT Devices
Hearing Implants
Diagnostic Devices
Electrosurgical Devices
Dental Equipment & Accessories
Diagnostic Imaging & MRI Systems
C/T Systems & Mammography Equipment
X-Ray & Ultrasound Systems
Nuclear Imaging Equipment
Contrast Media Injectors
Bone Densitometry
Anesthesia and Respiratory Devices
Anesthesia Machines & Disposables
Respiratory Devices & Disposables
Sleep Apnea Diagnostic Systems
Healthcare IT
Medical Imaging Information Systems
Nephrology and Urology Devices
Renal Dialysis Equipment
Orthopedic Devices
Orthobiologics & Arthroscopy
Joint Reconstruction
Trauma Fixation
Orthopedic Prosthetics
Cranium Maxillofacial Fixation (CMF)
Spinal Surgery
Endoscopy Devices & instruments
Rigid & Flexible Endoscope
In Vitro Diagnostics
Genetic Testing
Clinical Chemistry
Hematology
Immuno Chemistry
Infectious Immunology
Histology And Cytology
Patient Monitoring
Multiparameter Patient Monitoring
Micro-Electromechanical Systems
Non-invasive Blood Pressure Monitors
Neurology Devices
Neurostimulation Devices
Interventional Neurology
CSF Management
Neurosurgical Products
Radiosurgery
David Loucks is Chairman and Chief Executive of Healthios. Throughout his career, Mr.
Loucks has been an advisor, financier, and general manager throughout the healthcare
industry, in the process nurturing an experienced perspective on capital markets,
development cycles and value creation. Prior to co-founding Healthios in 2007, Mr.
Loucks, was the founder and Managing Partner of the Aethena Group, LLC., a private
equity partnership with a broad portfolio of investment interests. From 1998 until 2001,
Mr. Loucks served as President and CEO of Physician Dynamics, Inc. (PDI), a fullyintegrated provider of technology-enabled care management solutions for patients
afflicted with chronic and acute diseases. In September 2000, PDI was sold to Landacor, a
publicly-traded healthcare information technology company. Prior to Physician Dynamics,
from 1994 through 1998, Mr. Loucks was a Vice President with Robertson, Stephens &
Company, a global investment banking firm. Among his duties at Robertson Stephens, Mr.
Loucks was a founder of the Special Situations practice and he directed that firms first
international financing initiatives for companies based in Europe, Israel, India, and China.
Mr. Loucks holds a BA from Yale University and an MBA from Northwestern. As a rower,
Mr. Loucks is a former National Champion.
Managing Director
President and CEO
Direct: (847) 400-5000
Email: dloucks@healthios.com
Fritz Reichenbach
Managing Director
Direct: (847) 849-1775
Email: freichenbach@healthios.com
Diabetic Nephropathy
Diabetic Retinopathy
Hypercholesterolemia
Oral Mucositis
Gout
Acute Lymphocytic Leukemia
Bone Metastasis
Brain Cancer
Breast Cancer
Cervical Cancer
Chronic Lymphocytic Leukemia
Endometrial Cancer
Ewing Sarcoma
Gastric Cancer
Gastrointestinal Stromal Tumors
Head And Neck Cancer
Hodgkin Lymphoma
Kidney Cancer
Liver Cancer
Malignant Mesothelioma
Medullary Thyroid Cancer
Melanoma
Multiple Myeloma
Non-Hodgkin Lymphoma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Testicular Cancer
Thyroid Cancer
Age Related Macular Degeneration
Keratoconjunctivitis sicca (Dry Eye)
Retinal Vein Occlusion
Acute Respiratory Distress
Syndrome
Sepsis
Staphylococcal Infections
Acute Coronary Syndrome
Angina Pectoris
Atrial Fibrillation
Coronary Artery Disease (CAD)
Critical Limb Ischemia
Hypertension
Pulmonary Arterial Hypertension
Acute Pain
Anxiety Disorders
Chronic Pain
Dementia
Diabetic Neuropathy
Obsessive-Compulsive Disorder
Osteoarthritis Pain
Parkinson's Disease
Post-Traumatic Stress Disorder
Restless Legs Syndrome
Schizophrenia
Traumatic Brain Injury
Liver Cirrhosis
Childhood Enuresis
Growth Hormone Disorders
Hyperparathyroidism
Hyperthyroidism
Guillain-Barre Syndrome
Cytomegalovirus
Fungal Infections
Gram-Negative Bacterial Infections
H1N1 Infection
Herpes Zoster
HIV-1 Infection
Human Papillomavirus Infections
Staphylococcus Aureus (MRSA)
Third level
Fourth level
Fifth level
Managing Directors
Healthioss core team represents a unique assembly of experienced professionals, dedicated to
value creation within their client companies throughout the development cycle.
Christoph Brandenberger
Responsible for the
Cardiovascular Sector within
Healthios
Deal execution experience
across all healthcare sectors
Advised a diverse universe of
clients on M&A and financing
assignments, including mergers,
acquisitions, commercialization
and partnering agreements as
well as private placements
Extensive operational
experience working for a
European multinational
company
Previously with Montgomery
Securities in the Equity and
M&A Investment Banking
Group
University of Vienna, Austria;
MBA
Greg Shearer
Goucher College; BA
Georgetown University School
of Medicine, Ph.D., Microbiology
Schering Plough Corporation
8 major agreements
$2 billion annual
revenue/R&D effort
SVP, Bus. Dev., Human Genome
Sciences - Directed all
M&A/licensing
Partner, Oxford Bioscience
Partners
$1 billion portfolio of 149
companies
Board roles at: BrainCells,
Tragara, Claros, VaxInnate
Affinium, Intrapace, Applied
Spine Radius Health, Critical
Therapeutics
Centre College; BA
University of Chicago; MBA
Senior banker with Jefferies &
Company, Vector Securities and
Kidder, Peabody & Co.
Founder & Principal, Channel
Medical Partners
Involvement in well over 150
transactions across all sectors
of medical technology industry
Extensive background in both
investment banking and venture
industries
Victor Culiuc
Responsible for the Healthcare
Technology and Services
Joined Healthios in 2008
Prior experience includes:
Credit Suisse (M&A and then
Global Industrials and
Services Group)
International Monetary Fund
(IMF) in Washington DC
Advised a diverse universe of
clients on M&A and financing
assignments, including mergers,
acquisitions, commercialization
and partnering agreements as
well as private placements
Significant deal execution
experience across all healthcare
sectors
MBA, University of Chicago
Booth School of Business
S T R A T E G I C P AR T N E R I N G P AT H WAY
S T R A T E G I C P AR T N E R I N G P AT H WAY
PHASE 1:
Sector
Development
PHASE 2:
Positioning
PHASE 3:
Engagement
PHASE 4:
Relationship
PHASE 4:
Data
Analytics
PHASE 5:
Growth
PHASE 2:
Positioning
PHASE 3:
Engagement
PHASE 4:
Relationship
PHASE 4:
BIG
Data
PHASE 5:
Growth
Taking Action.
PHASE 2:
Positioning
PHASE 3:
Engagement
PHASE 4:
Relationship
PHASE 4:
BIG
Data
PHASE 5:
Growth
Selection &
Segmentation
Strategic Page
Custom Content
Targeting &
Tracking
18 million Data
Points
Opportunity
Origination
Assembling
EcoSystems
Communities &
Groups
Notifications
Messaging &
Alerts
3,000 Concurrent
Experiments
Site Visits
Company
Listings
Clinical &
Market Research
Private / Public
Valuations
Grand Rounds
WebCast
Trending &
Activity Scores
Due Diligence
Presentations &
O/M
Sector Pages
Xchange Live
Hosted Chat
Shark Tank
Milestones &
Inflection Points
LOI
Clinical /
Market Data
Xchange
LifeLines
Ratings &
Reviews
Xchange
Conferences
Sentiment &
Prediction
Tagging
Integrated Social
Media
Expert Opinion
WebCasts
Assembling
EcoSystems
Company
Listings
Presentations &
O/M
Clinical /
Market Data
Tagging
PHASE 2: Positioning
Strategic Page
Page
Strategic
Communities &
Groups
Clinical &
Market Research
Sector Pages
Xchange
LifeLines
Integrated Social
Media
Phase 3: Engagement
CustomContent
Content
Custom
Notifications
Private / Public
Valuations
Matching &
GeoLocation
Ratings &
Reviews
WebCasts &
Chat
Phase 4: Relationships
Targeting &
&
Targeting
Tracking
Tracking
Messaging &
Alerts
Grand Rounds
WebCast
Shark Tank
Xchange
Conferences
Type of
of event?
event?
Type
When
is
it
going
to happen?
happen?
When is it going to
How big
big will
will itit be?
be?
How
Target/Issuer
3,000 Concurrent
Experiments
The actual
actual number
number
The
of months
months before
before
of
the next
next
the
transaction
11.
transaction isis 11.
Wepredicted
predicted 10.
10.
We
Trending &
Activity Scores
Milestones &
Inflection Points
The actual
actual
The
number of
of
number
months before
before
months
the
next
the next
transaction isis 4.
4.
transaction
We
predicted
3.
We predicted 3.
Sentiment &
Prediction
Sector
State
Country
T1_Type
T1_Total_Value
Months from T1 and T2
T2_Type
T2_Total_Value
Months from T2 and T3
T3_Type
T3_Total_Value
Noveko
International Inc.
Diagnostic Imaging
Quebec
Canada
Private Placement
2.41
13
Private Placement
2.68
8
Private Placement
1.89
21.65
21.65
0.9106
The actual
actual value
value of
of the
the next
next transaction
transaction isis $21.65
$21.65
The
million and
and we
we predicted
predicted $21.65
$21.65 million.
million.
million
Merger and
and acquisition
acquisition
Merger
prediction.
Note that
that
prediction. Note
confidence isis aa bit
bit smaller
smaller
confidence
than
1.
than 1.
The actual
actual value
value of
of the
the next
next
The
transaction isis $150
$150 million
million
transaction
and
we
predicted
$150
and we predicted $150
million.
million.
Phase 6: Growth
Opportunity
Opportunity
Origination
Origination
Site Visits
Due Diligence
INSPIRATION
BIOPHARMACEUTICALS, INC.
Completed a strategic partnership with
$259,000,000
THE UNDERSIGNED ACTED AS EXCLUSIVE
FINANCIAL ADVISOR TO INSPIRATION
LOI
PHASE 2:
Positioning
PHASE 3:
Engagement
PHASE 4:
Relationship
PHASE 4:
Data
Analytics
PHASE 5:
Growth
Selection &
Segmentation
Strategic Page
Xchange
LifeLines
Targeting &
Tracking
18 million Data
Points
Opportunity
Origination
Assembling
EcoSystems
Communities &
Groups
Notifications
Messaging &
Alerts
3,000 Concurrent
Experiments
Site Visits
Company
Listings
Clinical &
Market Research
Private / Public
Valuations
Grand Rounds
WebCast
Trending &
Activity Scores
Due Diligence
Presentations &
O/M
Sector Pages
Xchange Live
Hosted Chat
Shark Tank
Milestones &
Inflection Points
LOI
Clinical /
Market Data
Xchange
Timeline
Ratings &
Reviews
Xchange
Conferences
Sentiment &
Prediction
Tagging
Integrated Social
Media
Expert Opinion
WebCasts
Company
Profile
Strategic
Profile
Going
Social
Taking
Action
Deal
Selection
Close